Related Experiment Video
Updated: May 31, 2026

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery
Published on: November 5, 2019
Cryptococcal meningitis in immunocompetent children
Zhu Yuanjie1, Chen Jianghan, Xu Nan
1Mycology Center & Department of Dermatology, Changzheng Hospital, Second Military Medical University, Shanghai, China.
Insights
Cryptococcal meningitis in immunocompetent children presents with varied symptoms. Early treatment with Amphotericin B and 5-flucytosine is crucial for successful outcomes, though visual damage can occur.
Area of Science:
- Pediatrics
- Infectious Diseases
- Neurology
Background:
- Cryptococcal meningitis is rare in immunocompetent children.
- Clinical presentation and optimal management require further elucidation.
Purpose of the Study:
- To detail the clinical features, treatment strategies, and outcomes of cryptococcal meningitis in immunocompetent children.
- To identify effective therapeutic regimens for this patient group.
Main Methods:
- Retrospective review of 11 immunocompetent children diagnosed with cryptococcal meningitis between 1998 and 2007.
- Analysis of clinical characteristics, treatment protocols, and patient outcomes.
Main Results:
- Common symptoms included headache, fever, and nausea/vomiting; visual/hearing impairment occurred in 36.4%.
- All patients received induction therapy with Amphotericin B (or liposomal AmB) plus 5-flucytosine, followed by fluconazole or itraconazole consolidation.
- Nine patients achieved mycological cure, with one experiencing sequelae of visual damage.
Conclusions:
- Cryptococcal meningitis in immunocompetent children can have nonspecific symptoms, with the central nervous system as the primary site of infection.
- Amphotericin B combined with 5-flucytosine is recommended as the preferred induction therapy.
Abstract:
To describe clinical characteristics, treatment and outcome of cryptococcal meningitis in immunocompetent children. Immunocompetent children with cryptococcal meningitis who attended Changzheng Hospital between 1998 and 2007 were retrospectively reviewed. During the 10 years reviewed, 11 children with cryptococcal meningitis were admitted to Changzheng hospital and identified as immunocompetent. The 11 children had a median age of 7.25 years. Headache (100%), fever (81.8%), nausea or vomiting (63.6%) and visual or hearing damage or loss (36.4%) were the most common symptoms before treatment. There is no evidence for other site infection of cryptococcus although all the cryptococcal antigen titre is high in blood. All the patients received amphotericin B or AmB liposome with 5-flucytosine for at least 6 weeks followed by fluconazole or itraconazole as consolidation treatment for at least 12 weeks. Nine patients were cured mycologically; however, sequela of visual damage was showed in one patient. Cryptococcal meningitis seems to be uncharacteristic of symptoms, and central nervous system may be the only common site for infection. Amphotericin B with 5-flucytosine should be the choice of induction treatment in this group of patients.
Related Concept Videos
Cryptococcal Meningitis
Cytomegalovirus Disease
Bacterial Meningitis I: Introduction
Encephalitis l: Introduction
Immunodeficiency Diseases
There are three main causes of immunodeficiency disorders...
Viral Meningitis